Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19

Passive immunotherapy with plasma derived from patients convalescent from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that Blood Establishments are prepared to satisfy requests for immune plasma by defining the requirements applicable to pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Accorsi, Patrizia, Berti, Pierluigi, de Angelis, Vincenzo, De Silvestro, Giustina, Mascaretti, Luca, Ostuni, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239775/
https://www.ncbi.nlm.nih.gov/pubmed/32532691
http://dx.doi.org/10.1016/j.transci.2020.102817
_version_ 1783536745678110720
author Accorsi, Patrizia
Berti, Pierluigi
de Angelis, Vincenzo
De Silvestro, Giustina
Mascaretti, Luca
Ostuni, Angelo
author_facet Accorsi, Patrizia
Berti, Pierluigi
de Angelis, Vincenzo
De Silvestro, Giustina
Mascaretti, Luca
Ostuni, Angelo
author_sort Accorsi, Patrizia
collection PubMed
description Passive immunotherapy with plasma derived from patients convalescent from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that Blood Establishments are prepared to satisfy requests for immune plasma by defining the requirements applicable to plasma donors and the standards for preparation, qualification, storage, distribution and control of use of the product. This position paper is aimed to give recommendations on biological characteristics of a plasma preparation from convalescent donors and to support the evaluation of this therapeutic approach in more rigorous investigations.
format Online
Article
Text
id pubmed-7239775
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72397752020-05-21 Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19 Accorsi, Patrizia Berti, Pierluigi de Angelis, Vincenzo De Silvestro, Giustina Mascaretti, Luca Ostuni, Angelo Transfus Apher Sci Article Passive immunotherapy with plasma derived from patients convalescent from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that Blood Establishments are prepared to satisfy requests for immune plasma by defining the requirements applicable to plasma donors and the standards for preparation, qualification, storage, distribution and control of use of the product. This position paper is aimed to give recommendations on biological characteristics of a plasma preparation from convalescent donors and to support the evaluation of this therapeutic approach in more rigorous investigations. Elsevier Ltd. 2020-08 2020-05-21 /pmc/articles/PMC7239775/ /pubmed/32532691 http://dx.doi.org/10.1016/j.transci.2020.102817 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Accorsi, Patrizia
Berti, Pierluigi
de Angelis, Vincenzo
De Silvestro, Giustina
Mascaretti, Luca
Ostuni, Angelo
Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19
title Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19
title_full Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19
title_fullStr Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19
title_full_unstemmed Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19
title_short Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19
title_sort position paper on the preparation of immune plasma to be used in the treatment of patients with covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239775/
https://www.ncbi.nlm.nih.gov/pubmed/32532691
http://dx.doi.org/10.1016/j.transci.2020.102817
work_keys_str_mv AT accorsipatrizia positionpaperonthepreparationofimmuneplasmatobeusedinthetreatmentofpatientswithcovid19
AT bertipierluigi positionpaperonthepreparationofimmuneplasmatobeusedinthetreatmentofpatientswithcovid19
AT deangelisvincenzo positionpaperonthepreparationofimmuneplasmatobeusedinthetreatmentofpatientswithcovid19
AT desilvestrogiustina positionpaperonthepreparationofimmuneplasmatobeusedinthetreatmentofpatientswithcovid19
AT mascarettiluca positionpaperonthepreparationofimmuneplasmatobeusedinthetreatmentofpatientswithcovid19
AT ostuniangelo positionpaperonthepreparationofimmuneplasmatobeusedinthetreatmentofpatientswithcovid19
AT positionpaperonthepreparationofimmuneplasmatobeusedinthetreatmentofpatientswithcovid19

Ejemplares similares